๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Prostate Cancer Patients

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester University of Southern California ยท Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan NCT06099093Phase 42 sites๐Ÿ“ Boston๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: 18F-DCFPyl Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer NCT07216248Phase 21 site๐Ÿ“ Salt Lake City University of Utah ยท Tests: relugolix + ARPI, Intermittent- Relugolix or androgen deprivation therapy (ADT) + ARPI, relugolix or androgen deprivatiโ€ฆ This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. NCT05946824Phase 21 site๐Ÿ“ Rochester University of Rochester ยท Tests: Daily-adaptive Stereotactic Body Radiation Therapy, Daily-adaptive Stereotactic Body Radiation Therapy The COSMYC Trial (COmbined Suppression of MYC) NCT06922318Phase 21 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: ZEN-3694, Testosterone cypionate, Enzalutamide, Luteinizing hormone-releasing hormone (LHRH) analogue A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer NCT06609005Phase 1, Phase 222 sites๐Ÿ“ Scottsdale๐Ÿ“ Newport Beach๐Ÿ“ Orange Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-9956 Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors NCT07288359Phase 1, Phase 216 sites๐Ÿ“ Atlanta๐Ÿ“ Nashville๐Ÿ“ San Antonio Novartis Pharmaceuticals ยท Tests: GVV858, Fulvestrant, Letrozole A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites๐Ÿ“ Fountain Valley๐Ÿ“ Jacksonville๐Ÿ“ Orlando Exelixis ยท Tests: XL309, Olaparib ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer NCT04986423Phase 231 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Whittier Zenith Epigenetics ยท Tests: ZEN003694, Enzalutamide Delayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer. NCT07357259NA1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna ยท Tests: Intervention Group Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer NCT05753566Phase 22 sites๐Ÿ“ Nanjing๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: Rezvilutamide, Androgen deprivation therapy (ADT), SRT Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial NCT06720532n/a1 site๐Ÿ“ Munich Hannah Schaefer ยท Tests: characterization of renal function., Handgrip strength test, Questionaires Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy NCT07711314Phase 21 site๐Ÿ“ Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Univeโ€ฆ ยท Tests: Rezvilutamide Tablets Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma NCT06567314Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ivonescimab Transperineal Versus Transrectal Cognitive Fusion Prostate Biopsy NCT07710807NA1 site๐Ÿ“ Ankara Ankara Etlik City Hospital ยท Tests: Transrectal Cognitive Fusion Prostate Biopsy, Transperineal Cognitive Fusion Prostate Biopsy Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer NCT07325721Phase 21 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Hypofractionated radiation with a microboost An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. NCT05939414Phase 3144 sites๐Ÿ“ Fayetteville๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Novartis Pharmaceuticals ยท Tests: AAA617, piflufolastat (18F), gallium (68Ga) gozetotide (25ฮผg) A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) NCT07723248Phase 312 sites๐Ÿ“ Coral Springs๐Ÿ“ Jeffersonville๐Ÿ“ Holland ORIC Pharmaceuticals ยท Tests: Rinzimetostat, Darolutamide, Enzalutamide, Docetaxel An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea NCT06334120n/a1 site๐Ÿ“ Multiple Locations Bayer ยท Tests: Darolutamide (Nubeqa, BAY1841788) PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer NCT07234981Phase 21 site๐Ÿ“ Omaha University of Nebraska ยท Tests: PSMA-guided Salvage Radiation Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer NCT06236139Phase 1, Phase 21 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Anti-STEAP1 CAR T-cells, Biopsy Procedure, Biospecimen Collection, Bone Scan, Computed Tomography The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer NCT07542379EARLY Phase 11 site๐Ÿ“ Wuxi FindCure Biosciences (ZhongShan) Co., Ltd. ยท Tests: 177Lu-FC516 PSMA-RLT in Biochemically Recurrent PCa NCT06220188Phase 21 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: [177Lu]Lu-PSMA I&T Carboplatin or Olaparib for BRcA Deficient Prostate Cancer NCT04038502Phase 218 sites๐Ÿ“ West Los Angeles๐Ÿ“ Aurora๐Ÿ“ Washington D.C. VA Office of Research and Development ยท Tests: Carboplatin, Olaparib A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer NCT06457919Phase 1, Phase 212 sites๐Ÿ“ New Haven๐Ÿ“ Basking Ridge๐Ÿ“ Middletown Memorial Sloan Kettering Cancer Center ยท Tests: Tinengotinib, abiraterone acetate with prednisone, Enzalutamide A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Sarasota๐Ÿ“ St Louis Angiex, Inc. ยท Tests: AGX101 A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan NCT07677267n/a1 site๐Ÿ“ East Hanover Novartis Pharmaceuticals Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors NCT06666270Phase 12 sites๐Ÿ“ Zhengzhou๐Ÿ“ Shanghai Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd ยท Tests: SYN818 PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan NCT07484269n/a1 site๐Ÿ“ Basel Novartis Pharmaceuticals
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy